MarketCap
Facebook
X
TelegramEyeGate Pharmaceuticals, Inc. Balance Sheet 2020-2011 | EYEG
Brief balance sheet overview of EyeGate Pharmaceuticals, Inc.
The balance sheet is assessed across five available annual reports spanning 2016 to 2020.
Total assets increased by +55.8%, from $9.7 million to $15.2 million. A CAGR near 11.7% points to substantial expansion.
Liability growth of -18.9% trailed asset growth of +55.8%. The funding structure became more resilient.
Negative net debt of -$823.6 thousand means cash holdings are larger than debt obligations.
The balance sheet carries negative retained earnings of -$108.3 million. The figure may result from accumulated losses or an active capital return policy.
Overall assessment
Taken together, the figures indicate acceptable resilience for EyeGate Pharmaceuticals, Inc.. The next assessment depends on debt and equity trends.
Annual Balance Sheet EyeGate Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-824 K | -3.69 M | -8 M | -7.79 M | -3.61 M | -8.39 M | 3.04 M | 1.53 M | -1.94 M | - |
Long Term Debt |
278 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
6.39 M | 2.08 M | 1.48 M | 1.4 M | 2.75 M | - | 36.4 M | 36.4 M | 36.4 M | - |
Total Current Liabilities |
1.77 M | 1.41 M | 3.86 M | 14.8 M | 7.31 M | 3.42 M | 5.02 M | 2.57 M | 747 K | - |
Total Liabilities |
8.16 M | 3.49 M | 5.34 M | 16.2 M | 10.1 M | 3.42 M | 41.4 M | 39 M | 37.2 M | - |
Deferred Revenue |
- | - | 2.69 M | 12.3 M | 4.22 M | 1.91 M | - | - | - | - |
Retained Earnings |
-108 M | -100 M | -93.2 M | -91.8 M | -78.6 M | -65.3 M | -56.9 M | -55.1 M | -51.2 M | - |
Total Assets |
15.2 M | 10.1 M | 14.3 M | 14.3 M | 9.73 M | 9.51 M | 1.41 M | 692 K | 2.34 M | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of EyeGate Pharmaceuticals, Inc., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Canada
China
France
Germany
Israel
Britain
Russia
Belgium
Cayman-islands
